Skip to main content
Journal cover image

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.

Publication ,  Journal Article
Thompson, AJ; Muir, AJ; Sulkowski, MS; Patel, K; Tillmann, HL; Clark, PJ; Naggie, S; Fellay, J; Ge, D; McCarthy, JJ; Goldstein, DB; McHutchison, JG
Published in: Hepatology
December 2010

Duke Scholars

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

December 2010

Volume

52

Issue

6

Start / End Page

2243 / 2244

Location

United States

Related Subject Headings

  • Recombinant Proteins
  • Polyethylene Glycols
  • Interleukins
  • Interferons
  • Interferon-alpha
  • Interferon alpha-2
  • Humans
  • Hepatitis C
  • Hepacivirus
  • Gastroenterology & Hepatology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thompson, A. J., Muir, A. J., Sulkowski, M. S., Patel, K., Tillmann, H. L., Clark, P. J., … McHutchison, J. G. (2010). Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype. Hepatology, 52(6), 2243–2244. https://doi.org/10.1002/hep.23826
Thompson, Alexander J., Andrew J. Muir, Mark S. Sulkowski, Keyur Patel, Hans L. Tillmann, Paul J. Clark, Susanna Naggie, et al. “Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.Hepatology 52, no. 6 (December 2010): 2243–44. https://doi.org/10.1002/hep.23826.
Thompson AJ, Muir AJ, Sulkowski MS, Patel K, Tillmann HL, Clark PJ, et al. Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype. Hepatology. 2010 Dec;52(6):2243–4.
Thompson, Alexander J., et al. “Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.Hepatology, vol. 52, no. 6, Dec. 2010, pp. 2243–44. Pubmed, doi:10.1002/hep.23826.
Thompson AJ, Muir AJ, Sulkowski MS, Patel K, Tillmann HL, Clark PJ, Naggie S, Fellay J, Ge D, McCarthy JJ, Goldstein DB, McHutchison JG. Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype. Hepatology. 2010 Dec;52(6):2243–2244.
Journal cover image

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

December 2010

Volume

52

Issue

6

Start / End Page

2243 / 2244

Location

United States

Related Subject Headings

  • Recombinant Proteins
  • Polyethylene Glycols
  • Interleukins
  • Interferons
  • Interferon-alpha
  • Interferon alpha-2
  • Humans
  • Hepatitis C
  • Hepacivirus
  • Gastroenterology & Hepatology